The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Global biosimilars market share in 2023, by region
Global market share of biosimilars by region 2023
In 2023, the global biosimilars market was estimated at some ** billion U.S. dollars. Of that, around one quarter was generated in Europe. This statistic displays the percentage of the global biosimilars market in 2023, by region.
Log in or register to access precise data.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Generics and biosimilars in the U.S.
Global Overview & Context
6
- Premium Statistic Pharmaceutical market size worldwide 2001-2029
- Basic Statistic Generic drugs market size worldwide 2023-2033
- Premium Statistic Global market forecast of biosimilars 2023-2033
- Premium Statistic Patent expiration risk for total worldwide global Rx drug revenue 2018-2032
- Premium Statistic Revenues of leading global generics manufacturers 2024
- Premium Statistic Global market share of biosimilars by region 2023
Competitive Landscape
5
- Premium Statistic Teva Pharmaceutical Industries' generic revenues by region 2022-2025
- Premium Statistic Generic drugs revenue top corporations in the U.S. 2023
- Premium Statistic Generics market share of top corporations in the U.S. 2023
- Premium Statistic Viatris' net sales 2022-2025, by market
- Premium Statistic Sandoz net sales in the U.S. 2022-2025
Market Penetration & Entry Pipeline
5
- Premium Statistic Top pharma products by prescriptions U.S. 2023
- Premium Statistic Number of ANDAs received in U.S. 2009-2023
- Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2020-2023
- Basic Statistic Projected small molecule sales at risk due to patent expiry in the U.S. 2019-2028
- Premium Statistic Sales share at risk of pharmaceuticals due to patent expiries U.S. 2022
Pricing & Payer Economics
6
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2024
- Premium Statistic Saving of U.S. costs through generic pharmaceuticals by condition 2024
- Premium Statistic Savings through generic drug usage in the U.S., by payer 2024
- Premium Statistic Total savings of top generic drugs in U.S. 2015-2024
- Premium Statistic Savings through generic drug usage in the U.S., by age group 2024
- Premium Statistic Price reduction of major Medicare expenditure drugs U.S. 2026
Biosimilar Market Acceleration
6
- Premium Statistic Share of filgrastim sales attributable to Neupogen or biosimilars US 2015-2024
- Premium Statistic Share of insulin glargine sales Lantus vs. biosimilar US 2015-2025
- Basic Statistic Number of biosimilars approved by FDA 2015-2025
- Basic Statistic New U.S. biosimilar launches of top products 2024-2029
- Premium Statistic Share of adalimumab sales Humira vs. biosimilars U.S. 2026
- Premium Statistic Adalimumab wholesale acquisition cost in the U.S. 2024
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
BioSpace. (June 17, 2024). Global biosimilars market share in 2023, by region [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 20, 2026, from /statistics/1538372/biosimilars-global-market-forecast/
BioSpace. "Global biosimilars market share in 2023, by region." Chart. June 17, 2024. ÌÇÐÄÆƽâ°æ. Accessed July 20, 2026. /statistics/1538372/biosimilars-global-market-forecast/
BioSpace. (2024). Global biosimilars market share in 2023, by region. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 20, 2026. /statistics/1538372/biosimilars-global-market-forecast/
BioSpace. "Global Biosimilars Market Share in 2023, by Region." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 17 Jun 2024, /statistics/1538372/biosimilars-global-market-forecast/
BioSpace, Global biosimilars market share in 2023, by region ÌÇÐÄÆƽâ°æ, /statistics/1538372/biosimilars-global-market-forecast/ (last visited July 20, 2026)
Global biosimilars market share in 2023, by region [Graph], BioSpace, June 17, 2024. [Online]. Available: /statistics/1538372/biosimilars-global-market-forecast/
Advertisement